ArticleJournal of translational medicine2023

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens.

Luhui Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.